STATE STREET CORP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$12,796,292
+24.9%
14,928,000
+25.2%
0.00%0.0%
Q2 2023$10,248,437
+2.6%
11,928,000
+3.0%
0.00%0.0%
Q1 2023$9,991,490
-55.8%
11,578,000
-54.6%
0.00%0.0%
Q4 2022$22,616,078
+86.1%
25,490,000
+85.4%
0.00%0.0%
Q3 2022$12,152,000
+10.2%
13,750,000
+8.7%
0.00%0.0%
Q2 2022$11,026,000
-11.9%
12,650,000
-8.0%
0.00%0.0%
Q1 2022$12,519,000
-22.9%
13,750,000
-21.9%
0.00%0.0%
Q4 2021$16,233,00017,600,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 135,834,000$118,179,3033.86%
STEELHEAD PARTNERS LLC 50,000,000$43,056,2502.73%
DeepCurrents Investment Group LLC 45,000,000$38,654,8931.53%
Opti Capital Management, LP 18,000,000$15,570,0001.32%
WOLVERINE ASSET MANAGEMENT LLC 58,557,000$50,549,2740.60%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,856,000$4,168,6020.59%
SHENKMAN CAPITAL MANAGEMENT INC 7,180,000$6,246,7940.49%
Context Capital Management, LLC 4,489$3,9060.35%
LINDEN ADVISORS LP 37,025,000$31,949,5340.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 14,000,000$12,091,1100.25%
View complete list of NOVOCURE LTD shareholders